Lipopolysaccharide (LPS) is the primary defensive molecule on the surface of Gram-negative bacteria, forming a dense molecular shield that blocks antibiotics, resists immune attacks, and maintains the structural integrity of the bacterial outer membrane. It works through several distinct mechanisms, from physically barring entry of harmful compounds to actively deflecting the weapons of the human immune system.
What LPS Is and Where It Sits
LPS is a large molecule made of three parts: a fatty anchor called lipid A that embeds in the outer membrane, a short chain of sugars called the core oligosaccharide, and a long, highly variable sugar chain called the O-antigen that extends outward from the cell surface. The O-antigen is built from repeating sequences of three to six sugar units, and its composition varies widely between bacterial species and even between strains of the same species.
These molecules pack tightly together across the entire outer surface of the bacterial membrane. Together they form the external layer of the outer membrane, functioning as both armor and identity card for the bacterium.
A Physical Barrier Against Antibiotics and Toxins
The most fundamental protection LPS provides is acting as a permeability barrier. Many antibiotics and toxic compounds are small, hydrophobic molecules that can normally slip through ordinary cell membranes made of phospholipids. LPS changes the equation. Its dense, ordered packing transforms the outer membrane into a surface these molecules cannot easily penetrate, making Gram-negative bacteria innately resistant to many antimicrobial compounds.
This barrier works because of lipid A’s unusual chemistry. Each lipid A molecule carries four to seven saturated fatty acid chains. These chains interact tightly with one another, creating a rigid, low-fluidity layer that small hydrophobic molecules struggle to cross. Think of it as the difference between trying to squeeze through a loosely woven net versus a tightly packed wall of bricks.
There’s a complication, though. LPS molecules carry negatively charged phosphate groups, and packing lots of negative charges close together would normally cause them to repel each other and loosen the barrier. Bacteria solve this by using positively charged metal ions, primarily magnesium and calcium, as molecular glue. These ions wedge between LPS molecules and form salt bridges that link the negatively charged phosphate and carboxyl groups together, dramatically strengthening the membrane’s integrity. This cross-linking is so critical that agents which strip away these ions (like the chemical EDTA or certain cationic antibiotics) can collapse the barrier entirely.
Blocking the Immune System’s Kill Shot
The O-antigen, that long sugar chain extending from the cell surface, plays a starring role in helping bacteria survive inside a host. One of the immune system’s most powerful weapons against bacteria is the membrane attack complex (MAC), a ring-shaped protein structure that punches holes in bacterial membranes. The O-antigen interferes with this process at its final step.
Research on Klebsiella bacteria showed that the O-antigen doesn’t stop the early stages of the immune attack. The immune system still deposits its targeting molecules on the bacterial surface and still generates the chemical signals that recruit immune cells. But the O-antigen prevents the final component of the MAC from properly inserting into and assembling within the bacterial membrane. Without that last piece locking into place, the pore never forms, and the bacterium survives.
The O-antigen also reduces how effectively bacteria get tagged for destruction by immune cells. In studies with Pseudomonas aeruginosa, bacteria with a full-length O-antigen had less of the immune tagging molecule C3b attached to their surface compared to mutant strains missing the O-antigen. Less tagging meant less uptake by neutrophils, the immune cells responsible for engulfing and destroying bacteria. Strains lacking the O-antigen were significantly more sensitive to killing by serum and showed reduced virulence, confirming the O-antigen as a major factor in bacterial survival during infection.
Surviving the Gut Environment
For enteric bacteria, those that live in or pass through the gastrointestinal tract, LPS provides protection against a different threat: bile salts. Bile salts are natural detergents produced by the liver, and they’re highly effective at disrupting cell membranes. Without a functional LPS layer, bacteria lose the lipid asymmetry of their outer membrane, allowing inner-layer phospholipids to migrate to the outer surface. This makes the membrane vulnerable to detergents like bile and SDS.
Interestingly, bacteria face a tradeoff here. Long O-antigen chains offer better protection against immune killing inside a host, but they can actually make the outer membrane slightly more permeable to other compounds. Short or absent O-antigen chains create a tighter permeability barrier but leave bacteria more exposed to immune attack. Enteric bacteria manage this balancing act by producing a mix of LPS molecules with different O-antigen lengths, optimizing for both environmental survival and immune evasion simultaneously.
Resisting Last-Resort Antibiotics
When conventional antibiotics fail against Gram-negative bacteria, clinicians turn to polymyxin antibiotics like colistin. These drugs work by targeting the negatively charged phosphate groups on lipid A, disrupting the membrane’s structure. But bacteria can fight back by chemically modifying their own lipid A.
The two main modifications involve attaching positively charged chemical groups to lipid A’s phosphate positions. One modification adds a sugar-based group to the phosphate at one position, while another adds a phosphoethanolamine group at a different position. Both changes reduce the overall negative charge of the membrane surface, preventing colistin from binding effectively. Some resistant strains carry chromosomal mutations that drive these modifications, while others acquire mobile resistance genes (MCR enzymes) that specifically add phosphoethanolamine to lipid A. The result is the same: the antibiotic can no longer grip the bacterial surface tightly enough to do its job.
How the Host Detects LPS
Despite all these protective functions for bacteria, LPS is also a liability. The human immune system has evolved a dedicated detection system for it. A protein in the blood called LPS-binding protein extracts LPS molecules from bacterial membranes and hands them off to a receptor called CD14. CD14 then presents LPS to a receptor complex on immune cells made up of two proteins, TLR4 and MD-2. When LPS binds, these receptor pairs come together and trigger two signaling pathways inside the cell, ultimately switching on the production of inflammatory molecules like TNF-alpha and IL-6.
This detection system is so sensitive that even tiny amounts of LPS can trigger a robust immune response, which is why Gram-negative bacterial infections often produce strong fevers and inflammation. The very molecule that protects bacteria from antibiotics and immune killing simultaneously serves as a beacon that alerts the immune system to the bacterial presence. This dual nature of LPS, protective shield and immune alarm, is central to the ongoing evolutionary arms race between Gram-negative bacteria and their hosts.